Latest filing published 27 Sept 2017 for Pure Bioscience, INC., €8,097.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -34.6%Entry US$1.07 · Close at T+365 US$0.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David J. Pfanzelter: trading record in brief
David J. Pfanzelter is a declared insider of Pure Bioscience, Inc., with filings sourced from SEC (Form 4). Between 23 October 2013 and 25 September 2017, the trades on record add up to 5 filings.
No open-market sale appears; the market trades are 2 purchases worth €44k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants and 1 option exercise.
Most recently, on 27 September 2017, the filings show an option exercise worth €8,097 in Pure Bioscience, Inc. The latest purchase dates back some time: it was published 4,079 days ago, on 9 September 2015. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David J. Pfanzelter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,000 shares@ US$0.60100.0% of flowCommon StockSEC:0001209191-17-054171:0
- 500,000 shares0Common StockSEC:0001209191-17-041856:0
- 40,000 shares@ US$0.75Common StockSEC:0001209191-15-069956:0Canonical exit: 30 Sept 2014 (T+90)
- 35,294 shares@ US$0.85Common StockSEC:0001209191-14-046112:0Canonical exit: 30 Sept 2014 (T+90)
- 2,800,000 shares0Common StockSEC:0001209191-13-049427:0
5 of 5 declarations
